tion of the blood network, the lymphatic system develops blind-ended capillaries, which converge into a larger collecting duct (the thoracic duct), ultimately merging into the anterior venous (2) . The formation of the entire vasculature network depends on the precise molecular control of proliferation, migration, and assembly of ECs, and also EC signaling for destabilizing and stabilizing the vasculature (1) . Understanding endothelial signaling during development in both embryonic and adult tissues is crucial in providing insights into the regulation of development and certain disease conditions such as cancer (3) .
Lysophosphatidic acid (LPA), a bioactive lipid, has diverse cellular (4) and signaling functions via its cognate cell surface G protein-coupled receptors (5, 6) , and it has been implicated as having an emerging role in a variety of cancers (4) . LPA receptor 1 (LPA 1 ) of the endothelial differentiation gene (Edg) subfamily (7) was the first receptor identified for LPA (8) . The lpa 1 gene is ubiquitously expressed at high levels in the colon, small intestine, placenta, brain, and heart, and moderately expressed in the pancreas, ovaries, and prostate (8) . Because of its high enrichment in the neurogenic ventricular zone, the lpa 1 gene was previously called ventricular zone gene-1 (vzg-1), and research mainly focused on studying its role in brain neurogenesis. A knockout mouse study initially failed to identify a role for LPA 1 in the developing brain (9) . However, a study using a variant of LPA 1 -null mice propagated from the original LPA 1 knockout mice, the so-called maLPA 1 mice, did exhibit a reduced ventricular zone, altered neuronal markers, and increased cell death (10) . Recently, we have demonstrated that LPA 1 is highly expressed in human umbilical vascular endothelial cells (HUVECs) (11) . The high expression of LPA 1 in ECs is very intriguing, as LPA has been suggested to play an important role in angiogenesis (12) . In addition, the LPA 1 was demonstrated to link pulmonary fibrosis to lung injury by regulating fibroblast recruit-ment and vascular leak (13) . LPA can regulate human EC proliferation (14, 15) , migration (14, 15) , capillarylike tube formation in vitro (16) , activation of proteases (17) , expression of inflammation-related genes (18) , and endothelial permeability (19) . It also mediates contractility, proliferation, and differentiation of vascular smooth muscle cells (20 -24) . Unsaturated LPA has been shown to trigger rat blood vessel remodeling in vivo (25) . Moreover, knocking out a synthesizing enzyme of LPA, autotaxin, causes lethality in mice on embryonic day 9.5, with profound vascular defects in the yolk sac (26) . These results suggest that LPA is essential for blood vessel formation during development. However, none of the LPA receptor knockout studies, including those using LPA 1 (9) , LPA 2 (27) , and LPA 3 (28) null-mice, reported defects in the vasculature except for a low incidence of cranial hemorrhage in LPA 1 and LPA 1 /LPA 2 null mice (9, 27) . Whether other recently identified LPA receptors, such as LPA 4 (29) and LPA 5 (30) , or complementary effects between LPA receptors, might have caused the lack of detectable vascular defects in those LPA receptor knockout mice is unclear. Thus, the role of LPA receptors in vascular development has remained an unresolved issue.
To study LPA receptor function, especially its role in vascular formation, we identified an lpa 1 gene in zebrafish, which is a well-established model for angiogenesis research (31, 32) . We demonstrate that knocking down LPA 1 translation results in inhibition of thoracic duct formation. In addition, these defects could be fully rescued by the ectopic expression of lpa 1 and partially ameliorated by a lymphangiogenic factor, vegf-c. Taken together, these results suggest that LPA 1 functions as a critical regulator directing lymphatic vessel development.
MATERIALS AND METHODS

Maintenance of zebrafish
Breeding wild-type (AB) and transgenic zebrafish (Tg(fli1: EGFP) y1 from the Zebrafish Information Research Center (Eugene, OR, USA) were cultured at 27-28°C on a 14-h light/10-h dark cycle. Embryos were collected by natural spawning, raised in 0.3ϫ Danieau's buffer [by diluting 1ϫ Danieau's buffer: 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , 0.6 mM Ca(NO 3 ) 2 , and 5.0 mM HEPES (pH 7.6), with double-distilled water] supplemented with 50 g/ml streptomycin and 50 g/ml penicillin G at 28.5°C until observation or fixation. Embryos were staged according to Kimmel et al. (33) , and stages are given as hours or days postfertilization (hpf or dpf, respectively). All animal handling procedures followed the guidelines for the use of laboratory animals at National Taiwan University, Taipei, Taiwan.
Cloning and analysis of the zebrafish lpa 1 gene
A reverse-transcription polymerase chain reaction (RT-PCR) was performed on total RNAs extracted from embryos at the designated times using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. RNAs were subsequently treated with DNase I (Invitrogen), and first-strand complementary (c) DNAs were synthesized. cDNAs were generated from total RNAs of 24-hpf zebrafish larvae by reverse transcription using the M-MLV reverse transcription kit (Promega, Madison, WI, USA). A 1208-base pair (bp) DNA fragment containing the coding region of the zebrafish lpa 1 gene (zlpa 1 , NM_001004502) was amplified from zebrafish embryo cDNAs by PCR using primers with the following sequences: 5Ј-GCGAGTGATTTCTGGACCTT-TCAGC-3Ј (forward) and 5Ј-GCCTTTTTCACAGTCTCTTCT-TGCG-3Ј (reverse). The amplified PCR fragment was subcloned into a pGEM-T easy vector (Promega) for sequence verification. Amino acid sequences of LPA 1 from different species among chordates were identified from the National Center for Biotechnology Information (NCBI) database and aligned using the Vector NTI software (Invitrogen). The phylogenetic tree was constructed and drawn using the MEGA3 software (Biodesign Institute, Tempe, AZ, USA).
RT-PCR analysis
RNAs and cDNAs from embryos at designated stages and from different adult tissues were prepared as described previously. A 136-bp zlpa 1 fragment was amplified with the following primers: 5Ј-CGGAGGGTAGTTGTGGTTATAG-3Ј (forward) and 5Ј-GGTACGAGTTGCTGTAGAGTG-3Ј (reverse). Amplification of a 542-bp ef1␣ fragment served as the RT-PCR internal control using the following primers: 5Ј-CAAGGAAGTCAGCGCATACA-3Ј (forward) and 5Ј-TGAT-GACCTGAGCGTTGAAG-3Ј (reverse).
Whole-mount in situ hybridization (WISH)
Embryos were grown to desired stages, fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) overnight, and manually dechorionated using fine forceps. Embryos were then stored in 100% methanol at Ϫ20°C until use. Antisense digoxigenin (DIG) -labeled RNA riboprobes were synthesized according to the manufacturer's instructions (Roche Applied Science, Penzberg, Germany). Hybridization and detection with an alkaline phosphatase-coupled anti-DIG antibody (Roche Applied Science) were performed according to Thisse et al. (34) . Photographs were taken with a Nikon Coolpix995 digital camera (Nikon, Tokyo, Japan). The image background was adjusted to the white point by the Curves tool of Adobe Photoshop (Adobe Systems, San Jose, CA, USA), and all channel output levels were set to 228. For cryosections, stained samples were immersed in PBS containing 30% sucrose overnight, and embedded in optimal cutting temperature (OCT) compound embedding medium (Sakura, Tokyo, Japan) at Ϫ20°C, and 10-m frozen cross-sections were cut with a CM 1900 rapid sectioning cryostat (Leica, Heidelberg, Germany) and attached to poly-l-lysine-coated slides (Electron Microscopy Sciences, Ft. Washington, PA, USA). Bright-field images were acquired with a TCS-SP5 confocal laser scanning microscope with a Leica HCX PL-APO ϫ63/ 1.30 glycerol objective (Leica Lasertechnik, Heidelberg, Germany) using a laser wavelength at 405 nm.
Morpholino oligonucleotides
Antisense morpholinos (MOs) were purchased from Open Biosystems (Huntsville, AL, USA) or custom made by Gene Tools (Philomath, OR, USA). To knockdown zlpa 1 gene activity, we used two nonoverlapping MOs targeting the boundaries flanking exon 2 to interfere with its splicing. The first splice-blocking MO was designated sMO 1 (sequence: 5Ј-TGGAGCACTTACCCAATACAATCAC-3Ј), which targets the boundary between exon 2 and intron 2 (Ϫ13 to ϩ12). The second splice-blocking MO was designated sMO 2 (sequence: 5Ј-GGTCTGTTTCTGAAAAGTAAAGATA-3Ј), which targets the boundary between intron 1 and exon 2 (Ϫ16 to ϩ9). A 5-bp mismatched splice-blocking MO of sMO 1 was generated to serve as a control with the following sequence, with the mismatched pairs in lowercase letters: 5Ј-TGcAGgACTTACCgAATAgAATgAC-3Ј. In addition, a reported zebrafish vegf-c (zvegf-c) MO (35) (with the sequence: 5Ј-GAAAATCAAATAAGTGCATTTTAG-3Ј) was purchased from GeneTools. The MOs were dissolved in sterile double-distilled water to 1 mM, stored at Ϫ20°C, and further diluted to the desired working concentrations in 1ϫ Danieau's buffer with 0.5% phenol red and kept at 4°C before being used.
Expression vector construction
The cDNAs of coding regions of zlpa 1 were amplified by RT-PCR and TA-cloned into the pcDNA3.1/V5-His-TOPO vector designed to express proteins with V5 and 6-histidine double fusions at the C-terminal under the CMV promoter (Invitrogen). The primers used were as follows: 5Ј-ATTGCG-GCCGCCATGGATGATAGACAATGCTA-3Ј (zlpa 1 , forward), 5Ј-ATTCTCGAGACCACTGAATGGTCATTATGGTGA-3Ј (zlpa 1 , reverse). The zvegf-c in the same expression vector as zlpa 1 was kindly provided by C. C. Huang (Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan).
Microinjection procedures
Microinjections were carried out according to Lai et al. (36) . Briefly, embryos at desired stages were immobilized in an injection trough on a 90-mm 2% agar plate. MOs or expression vectors were prepared as described at designated concentrations. An injection volume from 0.5-2.3 nl of different MOs, vectors, or vehicles was injected into 1-cell-stage embryos. After injection, embryos were recovered from the injection troughs and cultured in 0.3ϫ Danieau's buffer until being examined.
Photographs of vascular and lymphatic vessels
Blood or lymphatic vessels of Tg(fli1:EGFP) y1 zebrafish were observed under a DM5000B epifluorescent microscope (Leica, Wetzlar, Germany) with Leica HC PL Fluotar objectives using a fluorescein isothiocyanate (FITC) or rhodamine filter cube and imaged using a CoolSNAP fx CCD camera (Roper Scientific, Tucson, AZ, USA). The images were acquired using the SimplePCI program (ver. 5.2; Compix, Cranberry Township, PA, USA) and pseudocolored using green or red color for the FITC or rhodamine images, respectively.
Statistical analysis
All experimental values are presented as mean Ϯ sd and were analyzed by paired-sample Student's t test in Microsoft Excel (Microsoft, Redmond, WA, USA).
RESULTS
Cloning, sequencing, and expression profile analysis of lpa 1 To investigate the roles of LPA 1 during embryonic development, we first identified an lpa 1 gene (NM_001004502) from the NCBI database and isolated a 1208-bp DNA fragment by PCR amplification from zebrafish embryo cDNAs. This DNA fragment was subcloned, sequenced, and found to be 100% matched to the reported lpa 1 sequence from 141 to 1348 nucleotides of NM_001004502. It is referred as zlpa 1 hereafter. The gene, zlpa 1 , encodes a protein with 346 amino acids and a predicted molecular weight of 39.6 kDa. We aligned the translated amino acid sequences of zebrafish, mouse (NP_034466), and human (NP_001392) LPA 1 , and we found that they were highly homologous with a sequence identity of 85% (Fig. 1A) . A phylogenic analysis showed that zebrafish LPA 1 is most closely related to the LPA 1 of Fugu (Takifugu rubripes) among chordates (Fig. 1B) . To understand the chromosomal location of lpa 1 , we performed a syntenic analysis of these lpa 1 genes. The lpa 1 gene is located at chromosomes 10, 4, and 9 in the zebrafish, mouse, and human, respectively. They all have the same orientation and are positioned next to musk, a muscle-specific kinase receptor gene (Fig. 1C) . Collectively, these results suggest that zlpa 1 is evolutionarily related to mammalian lpa 1 genes. To investigate the spatial and temporal expression patterns of zlpa 1 , we synthesized its antisense riboprobe and used it for the WISH analysis. The WISH analysis revealed that zlpa 1 mRNAs were initially slightly expressed in the entire embryo before the completion of gastrulation. During somitogenesis, the zlpa 1 expression domain was restricted to adaxial cells flanking the notochord, head, and tail buds ( Fig. 2A, B) . It was notable that 18-somite-stage embryos exhibited moredistinct individual zlpa 1 expression domains restricted to adaxial cells and adjacent somites compared to 6-somite-stage embryos. At 24 hpf, zlpa 1 was highly expressed in the anterior head region (including eyes, midbrain/hindbrain boundary, and brain mesoderm) and tail terminal. In addition, zlpa 1 expression was also observed in the dorsal aorta and vicinity (Fig. 2C) . At the 31-hpf stage, the zlpa 1 expression domain was less prominent in the eyes and tail terminal but evident in brain mesoderm. In contrast, zlpa 1 expression still remained in the dorsal aorta and vicinity (Fig. 2D) . Transverse sections of the trunk region of 31-hpf embryos showed that zlpa 1 was expressed in a portion of the dorsal aorta and vicinity, including hypochord. It was also sporadically observed in the outside peripheral muscle regions but was excluded from neural tube and notochord (Fig. 2E) . Furthermore, to understand the zlpa 1 developmental gene expression profile, we analyzed its mRNA expression in zebrafish embryos at different stages from 1-cell to 7-dpf by RT-PCR. RT-PCR analysis showed that zlpa 1 was expressed in all early embryos and larvae up to 7 dpf (Fig. 2F ) and in all adult tissues examined (Fig. 2G) . The zlpa 1 was expressed at higher levels in the brain, eyes, ovaries, testes, gills, and swim bladder (Fig. 2G) .
Antisense MO interferes with zlpa 1 splicing and results in pericardial and truck edema
To study the roles of zLPA 1 during early embryogenesis, we used antisense MO oligonucleotides to knockdown zlpa 1 gene activity. The zlpa 1 gene consists of 3 exons and 2 introns, and a translation start site (ATG) is located at the 5Ј terminal of exon 2 (Fig. 3A) . Thus, we generated a splice-blocking MO (sMO 1 ), targeting the boundary between exon 2 and intron 2 to interfere with the splicing of exon 2. The sMO 1 was assumed to skip the transcription of exon 2, which subsequently would result in aberrant protein synthesis (Fig. 3B) . By the RT-PCR analysis, we demonstrated that the sMO 1 caused a shortening of zlpa 1 transcripts from 1208 bp in untreated control embryos to 453 bp in sMO 1 -treated embryos injected with 2.5 and 5 ng per embryo (Fig.  3C) . The 453-bp PCR fragment was sequenced and compared to the 1208-bp fragment. Sequence comparison revealed that the exon 2 was not transcribed as expected (Supplemental Fig. S1 ). The similar effect was also observed in embryos treated with 1.25 ng per embryo. In addition, the zlpa 1 -splice-blocking activity of sMO 1 remained active in treated embryos from 1 dpf to 5 dpf (Fig. 3D) . Thus, we used zlpa 1 -sMO 1 to explore LPA 1 's function in zebrafish development.
To test the dosage response, we first injected different amounts (1.25-5 ng per embryo) of zlpa 1 -sMO 1 into 1-cell stage embryos. The zlpa 1 -sMO 1 -treated embryos (zlpa 1 morphants) showed normal morphology during early development, but these zlpa 1 morphants gradually developed edema in the pericardial sac and body cavity (Fig. 4B) compared to the normal appearance of untreated zebrafish larvae (Fig. 4A ) after 4 dpf. Dose- dependently, these morphants also gradually showed blood flow retardation and failure in ventricle contraction (data not shown). Zebrafish embryos injected with 2.5 or 5 ng zlpa 1 -sMO 1 appeared very unhealthy; therefore, to avoid possible complications generated by high dosages, we subsequently used 1.25 ng unless otherwise stated. This dosage resulted in milder cardiovascular defects in ϳ30% of treated embryos, while the rest of embryos appeared healthy. zlpa 1 morphants exhibit defects in thoracic duct formation At 1.25 ng zlpa 1 -sMO 1 , 41.4 Ϯ 5.6% (nϭ78), embryos developed edema in the pericardial and trunk regions (Fig. 4B) . This zlpa 1 -sMO 1 -induced edema differs from those frequently observed edemas in various drugtreated or mutant zebrafish that mainly occur in the pericardial region. Thus, we decided to further examine this aspect. The occurrence of edema indicates an accumulation of interstitial fluids, which might result from vascular leakage or a failure of lymphatic vessels to absorb fluids. To examine the integrity of the vasculature, we examined the effects of zlpa 1 -sMO 1 in embryo vasculature using both wild-type and vasculature-fluorescent Tg(fli1:EGFP) y1 zebrafish (37) . No obvious defects in vasculature were observed in morphants, except some distortions of the patterning of the dorsal longitudinal anastomic vessel (DLAV), intersegmenal vessels (ISVs), supraintestinal artery (SIA), and subintetinal vein (SIV) after 5 dpf that might be caused by edema (data not shown).
To observe the lymphatic vasculature, we adapted an approach developed by two independent laboratories (38, 39) to monitor the development of lymphatic vessels in the presence or absence of zlpa 1 -sMO 1 . We successfully recorded the development of the thoracic duct, the largest lymphatic vessel connecting to the cardinal vein, in a zebrafish larva from 3 to 5 dpf (see Supplemental Fig. S2 ). The thoracic duct initially forms 1 (B, C) . Edema appeared in the pericardial sac and gut vicinity (arrows) in 5-dpf morphants (B). The zlpa 1 sMO 1 -induced edema was notably reduced by coinjecting 100 pg of the pcDNA 3.1 vector with zlpa 1 (C). Scale bar ϭ 1 mm.
as isolated islands (Supplemental Fig. S2A, B) , and the fusing of these islands gives rise to a complete vessel with lumen ( Supplemental Fig. S2C, D) . These observations were similar to those reported by Yaniv et al. (39) . In 5-dpf zlpa 1 morphants, thoracic ducts did not form (Fig. 5B, F) compared to those control ones with normal thoracic ducts (Fig. 5A, C) . Although only some of the zlpa 1 morphants injected with 1.25 ng zlpa 1 -sMO 1 exhibited mild cardiovascular defects, it was still possible that the absence of thoracic ducts in those zlpa 1 morphants might be a nonspecific secondary effect of cardiovascular defects. To further clarify this issue, we injected Tg(fli1:EGFP) y1 zebrafish embryos with 0.625 ng sMO 1 . We found no notable cardiovascular defects in the treated embryos, and examined the integrity of their thoracic ducts. In four trials, 87.1 Ϯ 17.7% of 46 zlpa 1 morphants showed defects in thoracic duct formation. Although the penetrance was lower and less consistent at this dosage, the experiment did show that the inhibition of thoracic duct formation by zlpa 1 -sMO 1 was specific and not secondary to the cardiovascular defects. In addition, we also tested the function of the thoracic duct using an intramuscular injection of rhodamine dextran and observed that the injected rhodamine dextran was absorbed by the thoracic duct of the untreated zebrafish (Fig. 5D, E) , but not that of the zlpa 1 morphants (Fig. 5G, H) .
To assure the specificity of zlpa 1 -sMO 1 in inhibiting thoracic duct formation and induction of edema, we examined the effects on zebrafish development of an sMO 1 5-bp mismatched MO (mis-sMO 1 ) and another zlpa 1 splice-blocking MO, sMO 2 , which targets the boundary between intron 1 and exon 2. RT-PCR analysis showed that the mis-sMO 1 had no effect on zlpa 1 transcript formation at up to 5 ng per embryo. In contrast, the sMO 2 caused missplicing of exon 2, as did sMO 1 , but some residual transcripts still remained intact, even when a higher amount of MO (10 ng/ embryo) was used (Fig. 3C) . Sequence analysis of zlpa 1 transcripts in those mis-sMO 1 and sMO 2 morphants demonstrated that they had the same sequences as those of control and sMO 1 -treated embryos, respectively (Supplemental Fig. S1 ). Using the numbers of segments between ISVs encompassed by the thoracic duct as an index, we analyzed the effects of different zlpa 1 MOs on the formation of the thoracic duct. We considered a thoracic duct with Ͼ6 segments in length in the examined region as normal. In three independent experiments, 100.0 Ϯ 0.0% of both the control and the mis-sMO 1 -treated embryos contained a normal thoracic duct. In contrast, there were significantly (PϽ0.01) lower percentages of embryos (9.1Ϯ3.5 and 25.7Ϯ6.1%) with a normal thoracic duct in the zlpa 1 -sMO 1 -and zlpa 1 -sMO 2 -treated groups, respectively (Fig.  6A) . The lower inhibitory effect of zlpa 1 -sMO 2 to block thoracic duct formation even at a higher dosage (7.5 ng/embryo) was presumably due to its lower potency in interfering with zlpa 1 splicing, as described (Fig. 3C) .
To confirm that zlpa 1 -sMO 1 -induced defects were due to loss of zlpa 1 , we coinjected zlpa 1 -sMO 1 with an expressing vector containing the zlpa 1 coding region, which does not contain the MO-targeting site, to see whether zlpa 1 -sMO 1 -induced defects could be rescued. Ectopic expression of zlpa 1 fully or partially rescued Ͼ80% of zebrafish larvae, which might have developed morphological defects, such as edema and the lack of a swim bladder, in the presence of zlpa 1 -sMO 1 (Fig. 4C) . The morphology of zlpa 1 -res- y1 zebrafish. After overnight culture, epifluorescent images collected with an ϫ20 objective were photographed to reveal the vasculature (C, F) and lymphatic vessels filled with rhodamine dextran (D, G) using FITC and rhodamine filters, respectively. In addition, superimposed images of C, D and F, G are shown in panels E and H, respectively. It appears that rhodamine dextran was absorbed by the lymphatic vessels, including the thoracic duct (arrows) and blind-ended lymphatic vessels (*) between intersegmental vessels in control zebrafish (D, E), but the uptake by the thoracic duct is not apparent in the zlpa 1 morphant (G, H) . DA, dorsal aorta; PCV, posterior cardinal vein. Scale bars ϭ 100 m (A, B); 50 m (A, B enlargements) ; 100 m (C-H).
cued zebrafish larvae (C) was indistinguishable from that of control ones (Fig. 4A) . The zlpa 1 -rescued zebrafish larvae contained a significantly (PϽ0.05) higher percentage (57.5Ϯ12.9%) of the normal thoracic duct (see representative photograph in Supplemental Fig. S3C ) compared to those injected with zlpa 1 -sMO 1 only (9.4Ϯ1.0%, Fig. 6B) . A higher percentage (18.9Ϯ4.6%) of rescued larvae was found to have a intermediately long thoracic duct (2 to 6 segments) compared to those of zlpa 1 morphants (9.6Ϯ8.4%, Fig. 6B) . Intriguingly, the lymphatic defect-inducing effect of zlpa 1 -sMO 1 could also be partially ameliorated (37.9Ϯ3.3 and 29.3Ϯ7.0% embryos with a thoracic duct Ͼ6 segments and 2 to 6 segments, respectively; PϽ0.05) by the ectopic expression of zebrafish vegf-c (Fig. 6C, nϭ4 , see representative photograph in Supplemental Fig. S3D ).
DISCUSSION
LPA is a bioactive lipid that is thought to regulate angiogenesis in normal and tumor tissues (12, 25, 40) . However, mice lacking the LPA receptors, LPA 1 and LPA 1 / LPA 2 , show no detectable defects in vasculogenesis or angiogenesis (9, 27) , rendering the regulatory mechanism of LPA-mediated vascular responses a puzzle. In this study, we report that zLPA 1 was expressed in the dorsal aorta and vicinity, and the knockdown of zLPA 1 resulted in high penetrance loss of the thoracic duct. The loss of the thoracic duct was specific to a reduction in LPA 1 activity, since it was consistently observed even at low zlpa 1 MO dosages and could be rescued by the ectopic expression of zlpa 1 . In addition, overexpression of zvegf-c, a well-known lymphangiogenic factor, was also able to partially ameliorate the zlpa 1 -morphant phenotypes. This further confirms the involvement of LPA 1 in mediating lymphangiogenesis in zebrafish. To our knowledge, this is a novel function of LPA receptor, and this is the first study implicating a G-protein-coupled receptor in the regulation of lymphangiogenesis.
Lysophospholipids, including LPA and sphingosine 1-phosphate (S1P), have long been implicated in cardiovascular development, where S1P appears to play a more prominent role in this aspect (41) . The zebrafish mutant, Miles apart, which encodes S1P 2 , was found to result in cardia bifida (42) . Although this is the first instance to suggest the role of S1P receptor in vertebrate development, the S1P 2 -null mice have no apparent anatomical or physiological defects at birth (43, 44) . On the other hand, S1P 1 -null mice exhibit strong defects in vascular smooth muscle recruitment, embryonic hemorrhage, and death (45) . In contrast to the prominent roles of S1P receptor in cardiovascular development, the LPA receptor-null mice do not reveal notable defects in the cardiovascular system (9, 27). However, half of the LPA 1 knockout mice died between late embryonic development and weaning. Although the neonatal death of those LPA 1 knockout mice was attributed to a suckling defect, it would be interesting to examine the integrity of the lymphatic system of those knockout mice. In addition, autotoxin-deficient mice die at embryonic day 9.5 showing profound vascular defect in yolk sac (26) . It further supports that LPA may work via one or more of its receptors to regulate vascular development.
There are at least five mammalian LPA receptors been identified, but only two of them, LPA 1 (9, 10, 27) and LPA 3 (28) have known in vivo functions by using the knockout mouse approach. More recently, a G protein-coupled receptor, P2Y5, has been shown to be a novel LPA receptor, which is involved in maintenance of human hair growth (46) . To explore zebrafish LPA receptors, we searched the zebrafish genome database and found LPA 1 , LPA 2 (NP_001003578), LPA 3 (XP_694990), and a predicted sequence of LPA 4 (XP_001334713). We have cloned LPA 1-3 but failed to obtain the LPA 4 , which only has a predicted sequence in the database. To compare their sequence similarity to mammalian LPA 1 , those zebrafish LPA 1-4 sequences were aligned with sequences of human and mouse LPA 1 (Supplemental Fig. S4 ). Sequence alignment showed that zebrafish LPA 1 is the closest homolog to mammalian LPA 1 . The sequence similarities of zebrafish LPA 1-4 compared to human or mouse LPA 1 are 89, 52, 45, and 12/13%, respectively (Supplemental Fig. S4B ). In addition, the phylogenetic tree analysis further reveals that zebrafish LPA 1 is indeed the closest homolog of mammalian LPA 1 (Supplemental Fig.  S4C ). The zLPA 1 contains 7 putative transmembrane domains (Fig. 1B) . In addition, Valentine et al. (47) have identified 5 critical LPA binding amino acid residues, including R3.28, Q3.29, W4.64, D5.38, and K7.36, which correspond to the zLPA 1 amino acid 106, 107, 168, 186, and 276 (Fig. 1A) , respectively, in the LPA receptors. Those amino acid residues are conserved except D5.38, in which an aspartic acid is replaced by an asparagine, in zLPA 1 as indicated in Fig.  1A . With the high sequence similarity and the conservation of ligand-binding residues to mammalian LPA 1 , the zLPA 1 is more likely to be an LPA receptor.
In this study, we confirmed the ubiquitous expression of zlpa 1 in various adult tissues (Fig. 2G) compared to its mouse homolog (8) . The WISH analysis demonstrated that zlpa 1 expression spreads through the entire blastodisc at a low level and is then restricted to adaxial cells, head, and tail buds at somatogenesis ( Fig. 2A, B) . Two types of muscle precursors are reported in zebrafish somites. Adaxial cells are located next to the notochord and form future slow-muscle fibers, whereas lateral somitic cells give rise to future fast-muscle cells (48, 49) . zlpa 1 appears only to be expressed in nonmigratory adaxial cells, since it was still located at the site juxtaposed to the notochord at the 18-somite stage (Fig. 2B ). This expression pattern is similar to that of engrailed 1b and the lymphatic master gene, prox1, at similar stages (50, 51) . These nonmigratory adaxial cells are muscle pioneers, which are known to be future slow-muscle cells that constitute the horizontal myoseptum (48, 49) . After 24 hpf, lpa 1 expression was heavily condensed in the eye and brain regions (Fig. 2C, D) , which is similar to that of its mammalian homologue (8) . Its expression was also found in the vicinity of the dorsal aorta (Fig. 2E) where vegf-c was expressed (52) The zlpa 1 expression domain encompassed only part of the dorsal aorta (Fig. 2E) . In contrast, the zvegf-c expression domain enclosed the entire dorsal aorta (data not shown). These partially overlapping signals of zlpa 1 and zvegf-c at the dorsal aorta suggest a possible linkage between them. In addition, the zlpa 1 expression domain appeared to include the hypochord, a transient structure in intimate association with notochord and dorsal aorta (53) . The hypochord is known to express VEGF and is essential for the development of dorsal aorta (54) . The expression of zLPA 1 in the hypochord and dorsal aorta suggests a role of zLPA 1 in vasculargenesis. However, knockdown of zLPA 1 appeared to have limited effects on blood vessels in zebrafish. It implies that the zLPA 1 may not be essential or other factors may be complementary to its regulation of blood vessels.
The lack of noticeable morphological defects observed for zlpa 1 morphants in the early stages suggests that zPLA 1 is not essential for early development, including blood vasculature formation. In contrast, the later appearance of edema in zlpa 1 morphants implies a tissue fluid imbalance. The requirement of adequate fluid balance increases with growth of zebrafish larvae. Therefore, the need for a functioning thoracic duct increases later in larval development. As shown in Supplemental Fig. S2 and also in results by Yaniv et al. (39) , a nearly complete thoracic duct is not formed until 5 dpf in zebrafish. The development of the thoracic duct coincides nicely to our observation that the edema of zlpa 1 morphants was also shown gradually after 4 or 5 dpf. Our observation that a functional thoracic duct was not formed on the treatment of zlpa 1 -MO (Fig. 5) further indicates that the edema was due to the lack of a thoracic duct. The blood vessels appeared normal prior to 5-dpf stage; however, we can not rule out the possibility that the vascular leakage might also contribute to the formation of edema in those zlpa 1 morphants.
The late appearance of zlpa 1 -MO phenotype raises the concern that it might not be a primary effect of MO since most MOs' activity are known to last for only 3 or 4 days in zebrafish embryos. In this regard, our RT-PCR analysis unequivocally showed that the zlpa 1 -MO still retained its splice-blocking activity in 5-dpf embryos, the oldest embryos examined in this study (Fig. 3D) . In addition, the splice blocking of antisense MO oligonucleotides is a commonly used approach to effectively knock down gene activity in zebrafish. However, one concern could be that the observed zlpa 1 -morphant phenotypes might be due to the dominant-negative effects of aberrantly translated proteins, but not the effects of zlpa 1 gene knockdown. Although MO-generated splice variants may be translated, they are often degraded after the first translation by nonsense-mediated decay, especially if the splice modification results in a frameshift. To further address this issue, we have sequenced the PCR products generated by the splice variants of sMO 1 and sMO 2 . Both splice variants, as expected, had eliminated the zlpa 1 Exon 2, as shown in Supplemental Fig. S1 . By the presence of a translation start site (ATG), we could identify 7 potential protein products with only one inframe protein that might be synthesized (Supplemental Fig. S1 ). With the assumption that those frameshift products were more likely to be degraded, we only discuss the possible effect of the inframe protein further. This possible inframe product is a 59-amino acid protein that comprises the end of the 7th transmembrane domain and the rest of C-terminal tail. By blasting this 59-amino acid sequence to the zebrafish protein database, there were only 5 hits except zLPA 1 (data not shown). A hypothetical protein (XP_694990.2) was found to have a highest identity of 18 in 25 amino acids. With the low-sequence homologies to other zebrafish proteins, even if this 59-amino acid protein were to produce a dominant-negative effect, it would still be specific to the zLPA 1 . Thus, the possible dominant-negative effect should not affect our conclusion. Furthermore, along with the zlpa 1 rescue experiments and consistent phenotypes obtained by the sMO 2 (but not the 5-bp mismatched sMO 1 ), we conclude that the loss of thoracic duct is specifically induced by knocking down zLPA 1 . We currently do not know whether the block of thoracic duct formation was a direct consequence of zLPA 1 knockdown; however, LPA has been shown to prime LPA receptor-expressing cells such as astrocytes to produce a specific secondary response to promote neuronal differentiation (55) . Therefore, the loss of the thoracic duct in zlpa 1 morphants is at least a specific secondary response by zlpa 1 knockdown, if not a primary one.
The present study suggests a possible link of LPA 1 with lymphangiogenesis. LPA 1 -mediated lymphangiogenesis may be dependent on or independent of VEGF-C signaling. Although LPA did induce LPA 1 -dependent expression of vegf-c in HUVECs in our preliminary trials (unpublished results), we failed to demonstrate consistent modulation of vegf-c expression on lpa1 knockdown or ectopic expression in zebrafish embryos by real-time PCR or WISH analyses (data not shown). These results imply that LPA and VEGF-C may work in parallel to modulate lymphatic vessel development. This finding is important because it provides a clue for examining how LPA may participate in cancer formation. LPA stimulates cell proliferation, migration, and survival. These LPA-evoked responses are hallmarks of tumor growth and metastasis (56) . Thus, when significant LPA levels were found to be present in malignant effusions and its receptors were expressed in several human cancer cells, it became an emerging candidate for a cancer marker (4) . LPA was also suggested to be a tumor inducer due to its capability of inducing cell motility and invasiveness, especially in both ECs (14 -16) and tumor cells (57) . VEGF-C and its receptor, VEGFR-3, are expressed in lymphatic endothelial cells and a variety of human tumor cells. Therefore, activation of the VEGF-C/VEGFR-3 axis in conjunction of LPA 1 signaling in lymphatic ECs can facilitate metastasis by stimulating lymphangiogenesis within and around tumors (58 -60) .
In summary, we have discovered a novel function of the LPA receptor, LPA 1 , as being a key receptor for mediating thoracic duct formation in zebrafish. Signaling for LPA 1 -mediated lymphangiogenesis possibly occurs in parallel to that of VEGF-C. These findings can assist our understanding of the molecular control of lymphangiogenesis in vivo, as well as help in unraveling the possible role of LPA in tumor metastasis through its regulation of lymphangiogenesis. 
